iollo
iollo is a healthcare company based in San Francisco, CA, and Zürich, ZH, offering at-home metabolomics tests and AI-driven health insights.
Company Overview
iollo is a healthcare company located in San Francisco, CA, USA, and Zürich, ZH, Switzerland, with a small team of three members. The company operates in the healthcare industry and provides at-home metabolomics tests. Founded under the Y-Combinator S22 batch, iollo offers services to various regions including the United States, Switzerland, and beyond, with options for remote engagement.
Services
iollo offers at-home metabolomics tests designed to measure over 500 biomarkers in blood samples. This service enables users to gain insights into dietary, behavioral, and therapeutic aspects of their health. The company uses AI to provide personalized health optimization recommendations, covering areas such as gut microbiome, aging, immune response, inflammation, hormonal balance, liver and kidney function, and bone health. Users receive comprehensive reports and can track their metabolic trends over time.
Technologies and Methods
iollo utilizes advanced mass spectrometry to quantify metabolites from blood samples, ensuring precise data collection. The company employs machine learning methods and artificial intelligence to analyze this data and generate personalized health insights. Their recommendations are based on peer-reviewed studies that have shown positive impacts on the metabolome and overall health.
User Engagement
iollo offers features enabling users to connect with each other, either through public or semi-public spaces. This promotes a community-driven approach to health optimization, allowing users to share experiences and insights. The platform supports longitudinal monitoring, enabling users to track changes and trends in their metabolomic profiles over time.
Research Partnerships
iollo is committed to advancing scientific knowledge and healthcare practices through strategic research partnerships. These collaborations are aimed at furthering the understanding of metabolomics and improving health outcomes based on their innovative services and technologies.
